1 week ago 7

News24 | WATCH | TUT's new humanoid robot could give people living with disabilities more access to AI

Share this via

The Tshwane University of Technology has acquired a new humanoid robot to expand the accessibility potential for people living with disabilities – for less than 20% of the normal cost.
Read Entire Article
  1. Homepage
  2. Headlines
  3. News24 | WATCH | TUT's new humanoid robot could give people living with disabilities more access to AI

From Twitter

Related

'The View' praises Jane Fonda for defending 'woke' at SAG awards, argues its 'ungodly' to oppose it

'The View' praises Jane Fonda for defending 'woke' at SAG aw...

42 minutes ago 0
Matthew Stafford wants $50 million to play in 2025 as Rams trade looms: report

Matthew Stafford wants $50 million to play in 2025 as Rams t...

54 minutes ago 0
Federal agency tells staff responses to Musk's DOGE productivity email may be read by 'malign foreign actors'

Federal agency tells staff responses to Musk's DOGE producti...

57 minutes ago 0
Terrifying video gives inside look at what it would be like to be eaten by a shark

Terrifying video gives inside look at what it would be like ...

1 hour ago 0

Comments

Trending

1. Monster Hunter Wilds
2. Ketamine
3. UPMC Memorial shooting
4. Eagles
5. Hims stock
6. Beyond the Gates
7. Apple 500 billion investment
8. Joel Embiid
9. Apple Stock
10. NVDA

Popular News

Trump administration fires more than a dozen immigration jud...
1 week ago
Trump administration fires more than a dozen immigration judges

Hamas hands over three Israeli captives in sixth phase of pr...
1 week ago
Hamas hands over three Israeli captives in sixth phase of prisoner exchange

Why has a former Tory MP decide to serve in Ukraine’s milita...
1 week ago
Why has a former Tory MP decide to serve in Ukraine’s military? | BBC News

'Cobra Kai' is a rare show that kids and adults both enjoy: ...
1 week ago
'Cobra Kai' is a rare show that kids and adults both enjoy: 'That's the really cool thing about' the series, its co-creator says

ASCO GU｜RemeGen Announced Highly Encouraging Data from the P...
1 week ago
ASCO GU｜RemeGen Announced Highly Encouraging Data from the Phase II Clinical Trial Evaluating Disitamab Vedotin plus Immunotherapy as Perioperative Regimen for Bladder Cancer
About Us · Contact Us · Terms & Conditions · Help · Privacy ·

© Latest News Search Engine - Global and Local Breaking News 2025. All rights are reserved